Elizabeth Tullis
St. Michael's Hospital(CA)University of Toronto(CA)Cystic Fibrosis Canada(CA)St Michael’s Hospital(IE)St Michael's Hospital(GB)St Michaels Hospital(GB)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Tracheal and airway disorders, Inhalation and Respiratory Drug Delivery, Transplantation: Methods and Outcomes
Most-Cited Works
- → A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation(2011)2,161 cited
- → Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele(2019)2,037 cited
- → Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial(2019)1,322 cited
- → VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles(2018)717 cited
- → Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice(2008)590 cited
- → Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis(2017)508 cited